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ABSTRACT
Objective To examine whether treatment of periodontal
diseasewithscalingandrootplaningduringpregnancyis
associated with a reduction in the preterm birth rate.
Design Systematic review and meta-analysis of
randomised controlled trials.
Data sources Cochrane Central Trials Registry, ISI Web of
Science, Medline, and reference lists of relevant studies
to July 2010; hand searches in key journals.
Study selection Randomised controlled trials including
pregnant women with documented periodontal disease
randomised to either treatment with scaling and root
planing or no treatment.
Data extraction Data were extracted by two independent
investigators, and a consensus was reached with the
involvementathird.Methodologicalqualityofthestudies
was assessed with the Cochrane’s risk of bias tool, and
trials were considered either high or low quality. The
primary outcome was preterm birth (<37 weeks).
Secondary outcomes were low birthweight infants
(<2500 g), spontaneous abortions/stillbirths, and overall
adversepregnancyoutcome(pretermbirth<37weeksand
spontaneous abortions/stillbirths).
Results 11 trials (with 6558 women) were included. Five
trials were considered to be of high methodological
quality(lowriskofbias),whereastherestwerelowquality
(high or unclear risk of bias). Results among low and high
quality trials were consistently diverse; low quality trials
supported a beneficial effect of treatment, and high
quality trials provided clear evidence that no such effect
exists. Among high quality studies, treatment had no
significanteffectontheoverallrateofpretermbirth(odds
ratio1.15,95%confidenceinterval0.95to1.40;P=0.15).
Furthermore, treatment did not reduce the rate of low
birthweight infants (odds ratio 1.07, 0.85 to 1.36;
P=0.55),spontaneousabortions/stillbirths(0.79,0.51to
1.22; P=0.28), or overall adverse pregnancy outcome
(preterm births <37 weeks and spontaneous abortions/
stillbirths) (1.09, 0.91 to 1.30; P=0.34).
ConclusionTreatmentofperiodontaldiseasewithscaling
and root planing cannot be considered to be an efficient
way of reducing the incidence of preterm birth. Women
may be advised to have periodical dental examinations
duringpregnancytotesttheirdentalstatusandmayhave
treatment for periodontal disease. However, they should
be told that such treatment during pregnancy is unlikely
to reduce the risk of preterm birth or low birthweight
infants.
INTRODUCTION
Periodontitisisarelativelycommonclinicalcondition,
which occurs in more than 30% of people in some
populations
1; it has a prevalence of between 5% and
20% in pregnant women.
2 Treatment in pregnancy is
safeandeasilyapplicableandinvolvesscalingandroot
planing.
3 An association between periodontal disease
and preterm birth has engendered much interest.
Despite advances in obstetric care, preterm birth con-
tinues to be the leading cause of perinatal morbidity
and mortality. This suggestion has led many investiga-
tors to seek evidence in this field. Since 1996, when a
relation of periodontal disease with preterm birth was
proposed,
4 many observational studies have been car-
ried out. Although the pathophysiological mechanism
remainsunclear,severalstudiessupportthehypothesis
that periodontal disease is associated with preterm
labour and other conditions complicating pregnancy,
such as pre-eclampsia and fetal growth restriction.
5
This association has also been reported by most of
the 17 observational studies up to 2005 that were
included in a meta-analysis published by Vergnes,
6
whichconcludedthatpregnantpatientswithperiodon-
tal disease have a 2.8-fold increased risk of preterm
birth.
Researchershavesuggestedthatperiodontaldisease
causes the release of pathogens or inflammatory pro-
ducts such as cytokines, which then affect embryonic
tissue or amniotic fluid through haematogenous
transport.
7 Taking into account the fact that treatment
of periodontal disease is simple and safe during
pregnancy,
3 many studies have examined whether
activemanagementofperiodontaldiseasehasapoten-
tialbeneficialeffectonoutcomesofpregnancy.In2006
several of the US insurers offered their clients scaling
and root planing during pregnancy at no extra cost,
8
saying that they expected that spending more on
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BMJ | ONLINE FIRST | bmj.com page 1 of 10preventive dental care would yield big savings in the
medicaltreatmentofcostlychronicillnesses.Although
the assumption that treatment of periodontitis would
haveapositiveresultonreducingtheincidenceofpre-
term births seems logical, broad investigation is essen-
tialtoreachvalidconclusions.Inthepast,treatmentof
conditions correlated with preterm birth, such as vagi-
nitis, failed to alter the incidence of preterm birth.
9-11
Between 2003 and 2008 seven prospective rando-
mised studies were published, and most of them
showed a decrease in preterm birth and low birth-
weightinfantsamongwomenwithperiodontaldisease
when the disease was treated, with scaling and root
planning, compared with no treatment. In contrast,
one of the largest studies showed no difference.
12
Whereas pooled results of the early trials supported
the hypothesis that applying treatment in patients
with periodontal disease may reduce the risk of pre-
termbirthandlowbirthweightinfants,
13thelowmeth-
odological quality of most of them prevented us from
prompt implementation of the findings. Today, after
the publication of more recent, well designed rando-
mised trials, a more comprehensive meta-analysis is
essential to provide solid guidelines for the treatment
of periodontal disease during pregnancy.
METHODS
Search strategy and eligibility criteria
Two independent investigators (DM and AV)
searched the Cochrane Central Trials Registry, ISI
WebofScience,andMedlinewithoutlanguagerestric-
tion up to July 2010 by using the search algorithm
“(periodontal disease OR periodontitis OR gingivitis)
AND(pretermlaborORpretermbirthORpremature
rupture of membranes OR low birthweight OR PTB
OR PROM OR LBW).” They compared the results
and reached a consensus on the eligibility of the trials
with the involvement of a third investigator (IPP). In
addition, we reviewed the references of all eligible
trials, did cross searches in Medline by using the
names of the investigators who were lead authors on
atleastoneeligibletrial,andhandsearchedthelasttwo
year volumes of two key dentistry journals (Journal of
Periodontology and Journal of Clinical Periodontology).
All randomised controlled trials that allocated preg-
nantwomentoreceivetreatmentwithscalingandroot
Scrutinised on basis of full text (n=39)
Reviews, editorials, letters, not relevant studies (n=23)
Excluded (n=574):
  On basis of title and abstract (n=540)
  Duplicates (n=34)
Potentially relevant reports identified and screened for retrieval
  from electronic search (n=613):
    PubMed (n=358)
    ISI Web of Science (n=232)
    Cochrane Library (n=23)
Randomised controlled trials (n=12)
Eligible randomised controlled trials (n=11)
Included patients with threatened preterm
birth receiving tocolytic agents (n=1)
Fig 1 | Flow chart of selection of trials
Table 1 |Baseline characteristics of included trials
Author, year Country
Total
No of
patients
No of
patients
followed
No of
live
births
Gestational age
at enrolment
(weeks)
Gestational age at
completion of treatment
(weeks) Definition of periodontal disease
Reclassification of severity of
disease inclusion criteria
according to CDC AAP 2003*
Lopez, 2002
21 Chile 400 372 358 9-21 28 ≥4teethwith≥1siteswithPD≥4mm
and CAL≥3m m
Mild periodontitis
Jeffcoat, 2003
20† USA 246 246 246 21-25 NA ≥3 sites with CAL≥3 mm Mild periodontitis
Lopez, 2005
22 Chile 870 856 845 <22 28 BOP≥25% ofsitesand nositeswith
CAL>2 mm
Gingivitis
Michalowicz,
2006
12†
USA 823 812 793 13-17 Until delivery when
necessary
4 or more teeth with PD≥4m ma n d
CAL≥2 mm and BOP>35% of sites
Mild periodontitis
Offenbacher,
2006
25
USA 74 67 67 <22 NA ≥2 sites with PD≥5 mm and CAL 1-
2m ma t≥1 sites with PD≥5m m
Moderate periodontitis
Sadatmansuri,
2006
26
Iran 30 30 30 13-20 30 ≥4teethwith≥1siteswithPD≥4mm
and CAL≥3m m
Mild periodontitis
Tarranum, 2007
24 India 220 192 188 9-21 28 CAL≥2m ma t≥50% of examined
sites
Mild periodontitis
Offenbacher,
2009
5†
USA 1806 1760 1761 <24 NA ≥3 periodontal sites with CAL≥3 Mild periodontitis
Newnham,
2009
23†
Australia 1087 1080 1073 12-20 28 ≥12 probing sites with PD≥4 Mild periodontitis
Macones, 2010
1† USA 756 713 720 6-20 NA CAL≥3m mo n≥3 teeth Mild periodontitis
Oliveira, 2010
19 Brazil 246 239 233 12-20 30-32 ≥1 sites with PD≥4m ma n d
CAL≥3m m
Mild periodontitis
BOP=bleeding on probing site; CAL=clinical attachment loss; NA=no data available; PD=probing depth.
*Mild periodontitis refers to category neither moderate nor severe periodontitis according to Centres for Disease Control and Prevention and American Association of Periodontology 2003
criteria; gingivitis is not included in clinical case definitions by CDC AAP 2003 but is in accordance with term proposed by International Workshop for a Classification of Periodontal Diseases
and Conditions in 1999.
†Trials considered to be of high methodological quality.
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ble for inclusion. We considered trials to be eligible if
they included patients with documented periodontal
disease (periodontitis or gingivitis), as defined by the
International Workshop for a Classification of Period-
ontalDiseasesandConditions.
14Alltrialswereeligible
regardless of the depth and the severity of periodontal
disease. We adopted a further classification of the
severity of periodontal disease based on the conclu-
sions of the working group by the Centers for Disease
ControlandPreventionandtheAmericanAssociation
ofPeriodontologyin2003.
15Wedefinedmoderateand
severe periodontitis, according to this classification, in
terms of probing depth and clinical attachment loss to
enhance case definitions and provide distinct cate-
gories.
For trials that, according to their protocol, had
included arms in which patients received concomitant
treatment (such as antibiotics), we focused on the sub-
groups of eligible patients. We excluded from the ana-
lysis randomised trials that included patients with
threatened preterm delivery who received tocolytic
agents, non-randomised trials, and pseudo-randomised
trials.
Data extraction and assessment of methodological quality
Two independent investigators (AZ and IPP) were
involved in the data extraction. A third investigator
(NPP) examined the results, and a consensus was
reached. We extracted the following data from each
arm of the eligible trials: authors’ names, journal and
yearofpublication,countryoforigin,enrolmentyears,
gestationalageatenrolment,gestationalageatcomple-
tion of treatment, number of patients randomised and
eligible, number of live births, and patients’ inclusion
criteria. In addition, we recorded the methodological
quality of the trials by using Cochrane’s risk of bias
tool.
16 Two independent investigators (NPP and DM)
assessed the methodological quality of the trials, and
consensus was reached.
Theprimaryoutcomewastherateofpretermbirths,
defined as the number of preterm births before
37 weeks of gestation (spontaneous or indicated)
among all successful pregnancies (all randomised
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Fig 2 | Risk of bias among included trials
Low quality trials
  Lopez 2002
  Lopez 2005
  Sadatmansuri 2006
  Offenbacher 2006
  Tarranum 2007
  Oliveira 2010
Subtotal (95% CI)
Test for heterogeneity: χ2=4.95, df=5, P=0.42, I2=0%
Test for overall effect: z=4.01, P<0.001
High quality trials
  Jeffcoat 2003
  Michalowicz 2006
  Offenbacher 2009
  Newnham 2009
  Macones 2010
Subtotal (95% CI)
Test for heterogeneity: χ2=4.02, df=4, P=0.40, I2=1%
Test for overall effect: z=1.45, P=0.15
Total (95% CI)
Test for heterogeneity: χ2=25.94, df=10, P=0.004, I
2=61%
Test for overall effect: z=0.86, P=0.39
0.55 (0.22 to 1.39)
0.51 (0.26 to 1.02)
0.12 (0.01 to 2.45)
0.45 (0.16 to 1.25)
0.36 (0.19 to 0.67)
0.84 (0.46 to 1.53)
0.52 (0.38 to 0.72)
0.43 (0.15 to 1.28)
1.14 (0.72 to 1.81)
1.27 (0.92 to 1.76)
1.04 (0.69 to 1.56)
1.29 (0.85 to 1.95)
1.15 (0.95 to 1.40)
0.93 (0.79 to 1.10)
4.2
7.3
1.1
3.6
11.1
7.9
35.2
3.5
11.4
21.8
15.1
13.1
64.8
100.0
0.1 0.2 0.5 1 2 5 10
Study or subgroup
Favours treatment Favours no treatment
Odds ratio
(M-H, fixed)
(95% CI)
Odds ratio
(M-H, fixed)
(95% CI)
Weight
(%)
7/168
18/563
0/15
9/35
53/99
27/116
114/996
5/123
44/402
91/881
52/538
58/359
250/2303
364/3299
Events/total
Treatment
14/190
17/282
3/15
14/32
68/89
31/117
147/725
11/123
38/391
73/880
50/535
47/361
219/2290
366/3015
Events/total
No treatment
Fig 3 | Meta-analysis plot for preterm birth <37 weeks of gestation. M-H=Mantel-Haenszel model
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nanciesthatledtospontaneousabortionsorstillbirths).
Secondary outcomes included the rate of low birth-
weight infants, defined as the number of infants under
2500 g among all successful pregnancies; the rate of
spontaneous abortions/stillbirths, defined as the num-
ber of spontaneous abortions or stillbirths among all
patients randomised except those lost to follow-up;
andtheoverallrateofadverseoutcomesofpregnancy,
defined as the number of preterm births (<37 weeks)
and the number of spontaneous abortions and still-
births, in an intention to treat analysis among all ran-
domised patients. Finally, other secondary outcomes
included the rate of spontaneous preterm births, rate
of preterm birth before 35 weeks of gestation, and rate
of very low birthweight infants (<1500 g).
Data analysis
We constructed two by two tables and calculated the
odds ratio for each primary study to estimate the rela-
tive risk of preterm birth, low birthweight infants, and
spontaneous abortion/stillbirth among the treatment
group compared with the control group. To test the
homogeneityofthe estimatesofoddsratiosamongeli-
gible studies, we used the χ
2 test with a level of signifi-
cance of 0.1, and we further quantified the degree of
heterogeneity by using the I
2 test. We synthesised
data across studies by using the fixed effects (Mantel-
Haenszel)modelwhenevernostatisticalheterogeneity
was apparent,
17 or by using the random effects model
(DerSimonian and Laird). Whenever studies reported
zeroeventsinbotharms(treatmentand notreatment),
we excluded these trials from the final analysis.
Weincludedalltrialsinthefinalanalysis.Becauseof
the increased heterogeneity seen after we pooled the
data from all the trials, we did separate meta-analyses
including only high quality or low quality trials. We
considered high quality trials to be those that had a
low risk of bias as was assessed by Cochrane’s risk of
bias tool. We detected the possibility of publication
bias visually by using contour funnel plots and tested
for small study effect bias with Harbord’s modified
test.
We used Review Manager (RevMan) version 5 sta-
tisticalsoftwaretoanalysedata.
16AllPvaluesweretwo
tailed with a level of significance of <0.05. We used
Stata SE 10.0 to do contour enhanced funnel plots
and Harbord’s test for small study effect bias.
RESULTS
Characteristics of eligible trials
We retrieved 613 reports through searches in the
CochraneCentralTrialsRegistry,ISIWebofScience,
and Medline. We did not identify any additional trials
through additional searches. We retrieved 12 rando-
mised controlled trials. However, we considered one
randomised trial to be ineligible because randomised
patients had been admitted to hospital for threatened
preterm birth and received tocolytic agents.
18 Another
recent trial did not clarify whether all patients in the
intervention arm received treatment with scaling and
root planing
19; however, personal contact with the pri-
mary investigators of the trial clarified that all patients
hadreceivedsuchtreatment.Finally,weconsidered11
trials to be eligible. These trials included 6558 patients
—3438 allocated to periodontal disease treatment and
Low quality trials
  Lopez 2002
  Lopez 2005
  Sadatmansuri 2006
  Tarranum 2007
  Oliveira 2010
Subtotal (95% CI)
Test for heterogeneity: χ2=4.78, df=4, P=0.31, I2=16%
Test for overall effect: z=4.03, P<0.001
High quality trials
  Michalowicz 2006
  Offenbacher 2009
  Macones 2010
Subtotal (95% CI)
Test for heterogeneity: χ2=2.26, df=2, P=0.32, I2=11%
Test for overall effect: z=0.60, P=0.55
Total (95% CI)
Test for heterogeneity: χ2=20.23, df=7, P=0.005, I2=65%
Test for overall effect: z=1.60, P=0.11
0.16 (0.02 to 1.29)
0.67 (0.15 to 2.99)
0.31 (0.01 to 8.28)
0.30 (0.17 to 0.56)
0.69 (0.38 to 1.28)
0.44 (0.30 to 0.66)
0.89 (0.57 to 1.41)
1.01 (0.72 to 1.43)
1.44 (0.91 to 2.28)
1.07 (0.85 to 1.36)
0.85 (0.70 to 1.04)
3.1
1.9
0.7
17.9
11.8
35.4
18.8
31.3
14.5
64.6
100.0
0.01 0.1 1 10 100
Study or subgroup
Favours treatment Favours no treatment
Odds ratio
(M-H, fixed)
(95% CI)
Odds ratio
(M-H, fixed)
(95% CI)
Weight
(%)
1/168
4/563
0/15
26/99
23/116
54/961
40/402
72/881
48/359
160/1642
214/2603
Events/total
Treatment
7/190
3/282
1/15
48/89
31/118
90/694
43/391
71/880
35/361
149/1632
239/2326
Events/total
No treatment
Fig 4 | Meta-analysis plot for low birthweight infants (<2500 g). M-H=Mantel-Haenszel model
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table shows the baseline characteristics of eligible
trials.
Methodological quality of trials
WeusedCochrane’sriskofbiastooltoassessthemeth-
odological quality of the trials (fig 2). Among eligible
trials, eight reported an adequate randomisation
mode,
151220-24 four used an adequate mode of
allocation concealment,
15122023, and six used
blinding.
1512202325 Overall, we considered five trials
to be of high methodological quality,
15122023 with a
low risk of bias. One study had an unclear risk of
bias, whereas the five remaining studies had a high
risk of bias.
Primary outcome—preterm birth (<37 weeks)
Pretermbirthswerereportedinalloftheeligibletrials.
Overall, 364 preterm births were reported in women
receiving treatment compared with 366 in patients
who received no treatment. Meta-analysis of the over-
all preterm birth rate indicated no difference when we
used either the random effects model (odds ratio 0.79,
95% confidence interval 0.58 to 1.06; P=0.12) or the
fixed effects model (0.93, 0.79 to 1.10; P=0.39). Sub-
groupanalysisaccordingtothemethodologicalquality
of randomised studies showed diverse results.
Whereas low quality trials supporteda significant ben-
eficial effect of treatment with scaling and root planing
on the rate of preterm birth (odds ratio 0.52, 0.38 to
0.72; P<0.0001), no such effect was apparent among
high quality studies (1.15, 0.95 to 1.40; P=0.15). Het-
erogeneity was present when we pooled all the trials
together but not for the separate analyses of high qual-
ity or low quality trials (fig 3).
Secondary outcomes
Low birthweight infants (<2500 g)
Thenumberoflowbirthweightinfantswasreportedin
eight of the eligible trials. Meta-analysis found no sig-
nificant difference between compared arms (odds
ratios 0.85, 0.70 to 1.04 (P=0.11) with fixed effects
model and 0.74, 0.49 to 1.12 (P=0.16) with random
effects model). Low quality and high quality trials
again differed in the effect of treatment (odds ratios
0.44, 0.30 to 0.66 (P<0.0001) for low quality trials
and 1.07, 0.85 to 1.36 (P=0.55) for high quality trials),
whereas heterogeneity was significant when we
included all the trials (Q=20.23, P=0.005, I
2=65%) but
not for either high quality or low quality studies sepa-
rately (fig 4).
Spontaneous abortion/stillbirth
All trials reported data for spontaneous abortions or
stillbirths. Three trials reported no outcomes in both
treatment and control arms,
202526 so we excluded
these from the final analysis. The pooled odds ratio
for the rate of spontaneous abortion/stillbirth was
0.84 (0.58 to 1.22; P=0.37), suggesting that no signifi-
cantdifferenceexists.Resultsremainednon-significant
Low quality trials
  Lopez 2002
  Lopez 2005
  Sadatmansuri 2006
  Offenbacher 2009
  Tarranum 2007
  Oliveira 2010
Subtotal (95% CI)
Test for heterogeneity: χ2=1.22, df=3, P=0.75, I
2=0%
Test for overall effect: z=0.01, P=1.00
High quality trials
  Jeffcoat 2003
  Michalowicz 2006
  Offenbacher 2009
  Newnham 2009
  Macones 2010
Subtotal (95% CI)
Test for heterogeneity: χ2=4.59, df=3, P=0.20, I2=35%
Test for overall effect: z=1.07, P=0.28
Total (95% CI)
Test for heterogeneity: χ2=6.07, df=7, P=0.53, I2=0%
Test for overall effect: z=0.91, P=0.37
1.51 (0.51 to 4.43)
0.88 (0.25 to 3.02)
Not estimable
Not estimable
0.90 (0.12 to 6.52)
0.50 (0.09 to 2.81)
1.00 (0.51 to 1.97)
Not estimable
0.35 (0.12 to 0.97)
1.00 (0.35 to 2.85)
0.40 (0.08 to 2.06)
1.13 (0.61 to 2.07)
0.79 (0.51 to 1.22)
0.84 (0.58 to 1.22)
8.8
8.5
0
0
3.3
6.3
26.9
0
22.4
11.2
8.1
31.4
73.1
100.0
0.01 1 100
Study or subgroup
Favours treatment Favours no treatment
Odds ratio
(M-H, fixed)
(95% CI)
Odds ratio
(M-H, fixed)
(95% CI)
Weight
(%)
8/176
7/570
0/15
0/35
2/101
2/118
19/1015
0/123
5/407
7/882
2/540
23/353
37/2305
56/3320
Events/total
Treatment
6/196
4/286
0/15
0/32
2/91
4/121
16/741
0/123
14/405
7/878
5/540
21/360
47/2306
63/3047
Events/total
No treatment
0.1 10
Fig 5 | Meta-analysis plot for spontaneous abortions/stillbirths. M-H=Mantel-Haenszel model
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trials(oddsratio0.79,0.51to1.22;P=0.28)orlowqual-
ity trials (1.00, 0.51 to 1.97; P=1.00) (fig 5). No signifi-
cant heterogeneity existed.
Overall adverse pregnancy outcomes
Data for the overall adverse pregnancy outcome (pre-
term birth <37 weeks and spontaneous abortions/still-
births)wereavailableforallofthetrials.Wecalculated
the odds ratio for this outcome in an intention to treat
analysis among all randomised patients. Statistically
significant heterogeneity was present (Q=26.45,
P=0.003, I
2= 62%). We found no significant difference
when we used either the random effects model (odds
ratio 0.78, 0.59 to 1.02; P=0.07) or the fixed effects
model(0.90,0.77to1.04;P=0.15).Lowquality studies
again tended to consistently overestimate the treat-
ment effect. When we did separate analyses according
to the methodological quality of the trials, low quality
trials showed a strong significant effect of treatment
(odds ratio 0.55, 0.41 to 0.73; P<0.0001), whereas
high quality studies showed that treatment had no
effect on the observed outcome (odds ratio 1.09, 0.91
to 1.30; P=0.34) (fig 6). We found no heterogeneity
between either high quality or low quality trials.
Other secondary outcomes
Other secondary outcomes were reported in fewer
thanhalfofthetrials(fig7),andresultsshouldbeinter-
preted with caution. Treatment with scaling and root
planing did not significantly improve the rate of spon-
taneous preterm birth (<37 weeks) (odds ratio 0.66,
0.37 to 1.17; P=0.12), preterm birth <35 weeks (1.22,
0.88 to 1.68; P=0.23), or very low birthweight infants
(<1500 g) (0.99, 0.61 to 1.60; P=0.97) (fig 7).
Publication bias
We assessed the presence of publication bias by using
the contour enhanced funnel plots.
27 The funnel plot
was asymmetrical (fig 8); less precise (smaller) studies
reported higher odds ratios than did larger studies
(Harbord’s test, P=0.002). Trials perceived to be miss-
ing were in parts where no statistical significance
existed, suggesting the presence of publication bias
(fig 8)
DISCUSSION
This meta-analysis shows that treatmentof periodonti-
tis with scaling and root planing in pregnant women
has no significant effect on the incidence of preterm
birth. Furthermore, treatment does not seem to have
a significant effect on the incidence of low birthweight
infants or spontaneous abortions/stillbirths or on the
overall rate of adverse outcomes of pregnancy (pre-
term births and spontaneous abortions/stillbirths).
Comparison with other studies
Theresultsofthismeta-analysisareincontrasttothose
of a previous meta-analysis published in 2009.
13 A
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours no treatment
Low quality trials
  Lopez 2002
  Lopez 2005
  Sadatmansuri 2006
  Offenbacher 2009
  Tarranum 2007
  Oliveira 2010
Subtotal (95% CI)
Test for heterogeneity: χ2=5.67, df=5, P=0.34, I
2=12%
Test for overall effect: z=4.16, P<0.001
High quality trials
  Jeffcoat 2003
  Michalowicz 2006
  Offenbacher 2009
  Newnham 2009
  Macones 2010
Subtotal (95% CI)
Test for heterogeneity: χ2=5.09, df=4, P=0.28, I2=21%
Test for overall effect: z=0.95, P=0.34
Total (95% CI)
Test for heterogeneity: χ2=26.45, df=10, P=0.003, I
2=62%
Test for overall effect: z=1.42, P=0.15
0.73 (0.36 to 1.47)
0.58 (0.32 to 1.05)
0.12 (0.01 to 2.45)
0.41 (0.15 to 1.14)
0.36 (0.21 to 0.63)
0.79 (0.45 to 1.40)
0.55 (0.41 to 0.73)
0.43 (0.15 to 1.28)
0.93 (0.61 to 1.41)
1.25 (0.92 to 1.71)
0.97 (0.65 to 1.44)
1.26 (0.88 to 1.80)
1.09 (0.91 to 1.30)
0.90 (0.77 to 1.04)
5.2
7.5
0.9
3.3
11.5
7.4
35.7
2.9
12.8
19.9
13.9
14.8
64.3
100.0
Study or subgroup Odds ratio
(M-H, fixed)
(95% CI)
Odds ratio
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Fig 6 | Meta-analysis plot for overall adverse pregnancy outcome (preterm birth <37 weeks of gestation and spontaneous
abortions/stillbirths). M-H=Mantel-Haenszel model
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page 6 of 10 BMJ | ONLINE FIRST | bmj.compotential reason for this discrepancy may be the fact
that the trials included in the earlier study had consid-
erable methodological shortcomings. Today, after the
publication of three new, well designed, large rando-
mised trials,
1523treatment of periodontal disease dur-
ing pregnancy does not seem to offer any clear benefit
for the reduction of preterm births or low birthweight
infants and therefore should not be routinely recom-
mended in pregnant women as a measure for preven-
tion of preterm birth.
Another reason for the discrepancy between this
meta-analysis and the previous one may be the poten-
tial threat of publication bias. Considerable evidence
from many clinical domains indicates that trials with
“negative”results,especiallysmallones,mayhavedif-
ficultygettingpublishedormaybepublishedwithcon-
siderable delays compared with trials that find
significant benefits for the tested interventions
2829; the
odds of publication are approximately four times
greater if the results are statistically significant.
30
Thus, early trials that did not favour treatment of per-
iodontal with scaling and root planing during preg-
nancy may have been left unpublished, resulting in
the accumulation of small trials with significant results
in favour of treatment. According to the funnel plot
constructed, publication bias is highly likely to exist.
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Fig 7 | Meta-analysis plots for other secondary outcomes: spontaneous preterm birth <37 weeks of gestation (top); preterm
birth <35 weeks of gestation (middle); very low birthweight infants (<1500 g) (bottom). M-H=Mantel-Haenszel model
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test for detecting small study effect bias showed that
small studies were more likely to provide inflated out-
comes in favour of the treatment arm. Despite the fact
that recent evidence suggests that in most meta-ana-
lyses the application of funnel plot asymmetry tests to
detect publication bias is inappropriate or not mean-
ingful, especially when few trials are included in the
meta-analysis,
31 we applied the contour enhanced fun-
nel plots, which seem to be more convincing in detect-
ing publication bias.
27
Strengths and limitations of study
The most important strength of this study is the large
sample size of patients included among high quality
trials. Despite the fact that less than half of the trials
were of high methodological quality, they cumula-
tively included more than 4500 patients, with a 65%
weight in the overall estimate of the pooled study
effect. This constitutes a large sample size, sufficiently
powered to exclude at least a 2.5% reduction in the
incidence of preterm birth after treatment with scaling
and root planing, given that the preterm birth rate in
the United States is around 12%.
32
Another advantage of this meta-analysis is that we
separately analysed our results according to the meth-
odological quality of the studies. The most interesting
observationisthecompletelydifferentresultsobtained
when we pooled the data separately from low quality
and high quality trials for most of the primary and sec-
ondary outcomes. Strong statistical significance was
achieved when we included only low quality trials,
and this significance completely disappeared when
we considered only high quality trials. One should be
cautious when interpreting the data from low quality
randomisedtrialsandpossiblyreconsidertheadoption
of outcomes retrieved from such trials. Considering
that only two of the early trials published up to 2008
reported key methodological parameters for rando-
mised trials,
1220 the discrepancy between the results
of our previous analysis and this one should be unde-
niably attributed to the suboptimal quality of the early
trials. The subgroups analyses we did for all the out-
comes clearly support this hypothesis, as low quality
trials showed a strong significant effect of treatment
whereas high quality trials reported no difference in
any of the outcomes tested.
Poor reportingof themethodologicalcharacteristics
of randomised trials has been previously described.
33
Although a substantial improvement in key aspects of
trials’ methods has been seen over the past years, the
quality of reporting remains well below an acceptable
level.
34 The most important aspect related to the sub-
optimal methodological quality of randomised trials is
the substantial threat to the validity of the results and
conclusions obtained. Reporting of methodological
quality parameters is directly correlated with the pro-
vision of outcomes that favour the experimental
arm.
3536 Previous reports have shown an inverse rela-
tion between the methodological quality score and the
efficacy of preventive strategies,
37 whereas the quality
ofreportsofrandomisedtrialsseemstoaffectestimates
of the efficacy of interventions reported in meta-
analyses.
38 Thus, taking into account the fact that stu-
dies of low methodological quality in which the esti-
mate of quality is incorporated into the meta-analyses
can alter the interpretation of the benefit of the inter
vention,
38 this meta-analysis has a major strength in
that it separately considered the effect of treatment
amonghighqualityandlowqualitytrials.Thisisaccor-
dance with a large meta-epidemiological study, which
clearly recommends that systematic reviewers should
present meta-analyses restricted to trials at low risk of
biasforeachoutcome,eitherastheprimaryanalysisor
in conjunction with less restrictive analyses.
39 Further-
more, the adoption of Cochrane’s risk of bias tool to
assess the quality of the randomised trials included in
our review is another advantage, given that it is a vali-
dated tool developed to overcome some of the short-
comings of existing quality assessment instruments.
40
Ourmeta-analysishascertainlimitations.Firstly,the
definition of periodontal disease differed among the
trials included. A recent position paper commissioned
by the European Association of Dental Public Health
showed a distinct lack of consensus and uniformity in
the definition of periodontitis in epidemiological
studies.
41 Furthermore, a review showed that the sig-
nificance of the association between periodontal dis-
ease and pregnancy outcomes may be determined by
the definition or measurement of periodontal disease
used.
42 This discrepancy in the definition of periodon-
tal disease is also present in the trials of treatment of
periodontal disease during pregnancy. However, we
re-evaluated the severity of periodontal disease
among patients included within the trials, on the basis
on the classification proposed by the Centres for Dis-
ease Control and Prevention and the American Asso-
ciation of Periodontology in 2003.
15 On the basis of
trials’ inclusion criteria, the five high quality trials
hadcomparableinclusioncriteriaasregardsthesever-
ity of disease (table). Consequently, differences in the
definition of the disease are unlikely to have contribu-
ted to the lack of effect of treatment.
Secondly, one of the trials included in the main ana-
lysis enrolled only patients with gingivitis who were
treated with scaling.
22 These patients might have had
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ment,astheywerewomenwithlesssevereperiodontal
disease and the effect of treatment on the rate of pre-
termbirthmayhavebeengreater.However,thisstudy
hadimportantmethodologicalshortcomingsandhada
significantly higher percentage of patients with a pre-
vious history of preterm birth in the treatment arm, so
we did not include it in the analysis of high quality stu-
dies. Furthermore, considering the positive results of
the trial, exclusion from the main analysis would
have not affected our results.
Finally, according to our tests, an increased likeli-
hood of publication bias exists in our analysis. How-
ever, given that publication bias usually involves
trials with “negative” results,
29 any unpublished trial
would be highly unlikely to have favoured the treat-
ment arm. Furthermore, taking into account the qual-
ity of the five highest quality trials included here and
their weight in the overall analysis, the effect of any
unpublished or missed trial on the overall effect of
treatment would probably be detrimental.
Conclusions and policy implications
Inanattempttoexplainthelackofasignificanteffectof
treatment of periodontal disease during pregnancy on
perinatal outcomes, we could speculate that treatment
withscalingandrootplaningdoesnotalterthesequence
of events leading from regional inflammation due to
periodontitistosystemicinflammationandonsetofpre-
term birth. This lack of treatment effect may be related
to the diverse systemic response after scaling and root
planing on different stages of periodontal disease. For
example, in non-pregnant patients with documented
periodontal disease, non-surgical treatment results in
different local and systemic inflammatory responses.
43
Furthermore,in more severe cases,treatmentmay lead
to higher levels of circulatory inflammatory
cytokines.
744Asubgroupanalysisinourpreviousreport
showed that treatment was significantly more effective
when applied in patients with less severe disease. How-
ever, our updated meta-analysis now includes five high
qualitytrials,amongwhichthedefinitionofperiodontal
diseasedoesnotdifferwidely.Thus,takingintoaccount
the fact that none of the outcomes among these trials
favouredtreatmentwithscalingandrootplaningduring
pregnancy, such treatment is unlikely to have any ben-
eficial effect on perinatal outcomes.
Some investigators suggest that adjuvant antibiotic
treatment could be used in patients with periodontal
disease to prevent preterm birth. However, the bene-
ficial effect of antibiotic treatment in reducing the inci-
dence of preterm birth, either among patients with
periodontal disease or among those with other infec-
tions, is controversial. The only randomised trial that
allocated patients to a combination of scaling and root
planing and administration of antibiotic failed to sup-
port this hypothesis,
20 and previous meta-analyses
failed to show a significant effect of antibiotics on the
incidence of preterm birth when given for the treat-
ment of bacterial vaginosis.
9-11
Another consideration is that the success of period-
ontal disease treatment may indeed be a determinant
of the effect of scaling and root planing on the overall
incidence of preterm birth. Some randomised trials
included in our meta-analysis examined periodontal
status only before delivery and not after treatment.
Consequently, a well designed prospective rando-
mised trial to test whether pregnant patients who
have successfully controlled their periodontal disease
mayeventuallyhaveasubstantiallyreducedincidence
of preterm birth would be of interest.
Finally, despite the fact that we failed to show any
benefit of treatment during pregnancy, we cannot
excludethepossibilitythatwomenwhostarttreatment
and have their periodontal disease controlled early in
the first trimester of pregnancy or even before becom-
ing pregnant, may have a substantial improvement in
perinataloutcomes.Althoughwe cannot besure thata
causal relation between periodontal disease and pre-
termbirthexists,thelikelihoodofanassociationisvery
high.
6Therefore,pre-pregnancytreatmentseemstobe
areasonablealternative,andarandomisedtrialinclud-
ing patients allocated to scaling and root planing or
control before pregnancy and examining its effect in
a subsequent pregnancy may show significant differ-
ences in the future. However, given that many preg-
nancies are unplanned, such a trial would be very
difficult to do and would need a large sample size.
Inconclusion,updatedevidencedoesnotencourage
the use of scaling and root planing as an efficient
method of reducing the rate of preterm birth or
improving perinatal outcomes. Women may be
advised to evaluate their dental status during preg-
nancyandmayhavetreatmentforperiodontaldisease.
However, they should be told that such a treatment
during pregnancy is unlikely to reduce the risk of pre-
term birth or low birthweight infants and therefore
should not be considered as routine antenatal care.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Periodontal disease is associated with an increased risk of preterm birth, and a causal
relation may exist
Existing reports on the effect of treatment with scaling and root planning on the incidence of
preterm birth are conflicting
WHAT THIS STUDY ADDS
Treatment of periodontal disease with scaling and root planing during pregnancy does not
reduce the risk of preterm birth and should not be routinely recommended as a measure to
prevent preterm birth
Randomisedtrialsoflowmethodologicalqualitytendtooverestimatetheeffectoftreatment,
whereas high quality trials provide strong evidence that no significant effect of treatment
exists
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